Skip to main content
Midas Edge

Outlook Therapeutics Inc

For the period ended Sep 30, 2024. Filed Dec 27, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Dec 27, 2024

OTLK$0.46+5.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

​​​​​​​
​ · ​ · September 30,
​​20242023
​​​​​​​
Assets​​​​​​
Current assets:​​​​​​
Cash and cash equivalents​$14,927,538​$23,391,982
Prepaid expenses and other current assets​​12,488,498​​7,587,216
Total current assets​​27,416,036​​30,979,198
​​​​​​​
Operating lease right-of-use assets, net​​274,645​​26,172
Equity method investment​​693,190​​793,932
Other assets​​439,283​​501,299
Total assets​$28,823,154​$32,300,601
​​​​​​​
Liabilities and stockholders’ deficit​​​​​​
​​​​​​​
Current liabilities:​​​​​​
Unsecured convertible promissory note​$29,440,000​$35,551,000
Finance lease liabilities​​—​​4,267
Current portion of operating lease liabilities​​50,907​​—
Accounts payable​​7,968,725​​6,574,523
Accrued expenses​​3,237,468​​2,745,740
Income taxes payable​​1,856,629​​1,856,629
Total current liabilities​​42,553,729​​46,732,159
​​​​​​​
Operating lease liabilities​​246,922​​—
Warrant liability​​59,099,013​​6,219
Total liabilities​​101,899,664​​46,738,378
​​​​​​​
Commitments and contingencies (Note 8)​​​​​​
​​​​​​​
Stockholders’ deficit:​​​​​​
Preferred stock, par value $0.01 per share: 10,000,000 shares authorized, no shares issued and outstanding​​—​​—
Common stock, par value $0.01 per share; 60,000,000 shares authorized; 23,905,635 and 13,012,833 shares issued and outstanding at September 30, 2024 and September 30, 2023, respectively​​239,057​​130,128
Additional paid-in capital​​469,969,333​​453,350,281
Accumulated deficit​​(543,284,900)​​(467,918,186)
Total stockholders' deficit​​(73,076,510)​​(14,437,777)
Total liabilities and stockholders' deficit​$28,823,154​$32,300,601

See accompanying notes to consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.